Evidence map›Paper›PMID 26697498›Full record

ArticleJournal of diabetes research2016

Inhibition of NA(+)/H(+) Exchanger 1 Attenuates Renal Dysfunction Induced by Advanced Glycation End Products in Rats.

Peng Li, Geng-Rong Chen, Fu Wang, Ping Xu, Li-Ying Liu, Ya-Ling Yin, Shuang-Xi Wang

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Peng LiCollege of Pharmacy, Xinxiang Medical University, Xinxiang 453003, China ; Department of Pharmacology, Pharmaceutical College, Central South University, Changsha 410078, China.
Geng-Rong ChenDepartment of Pharmacology, Pharmaceutical College, Central South University, Changsha 410078, China.
Fu WangThe Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Qilu Hospital, School of Medicine, Shandong University, Jinan 250012, China.
Ping XuCollege of Pharmacy, Xinxiang Medical University, Xinxiang 453003, China.
Li-Ying LiuDepartment of Pharmacology, Pharmaceutical College, Central South University, Changsha 410078, China ; Medical College of San-Quan, Xinxiang Medical University, Xinxiang 453003, China.
Ya-Ling YinCollege of Pharmacy, Xinxiang Medical University, Xinxiang 453003, China ; School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Shuang-Xi WangCollege of Pharmacy, Xinxiang Medical University, Xinxiang 453003, China ; The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Qilu Hospital, School of Medicine, Shandong University, Jinan 250012, China.
Central South University · CNXinxiang Medical University · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been recognized that sodium hydrogen exchanger 1 (NHE1) is involved in the development of diabetic nephropathy. The role of NHE1 in kidney dysfunction induced by advanced glycation end products (AGEs) remains unknown. Renal damage was induced by AGEs via tail vein injections in rats. Function and morphology of kidney were determined. Compared to vehicle- or BSA-treated rats, AGEs caused abnormalities of kidney structures and functions in rats, accompanied with higher MDA level and lower GSH content. Gene expressions of NHE1 gene and TGF-β1 in the renal cortex and urine were also increased in AGEs-injected rats. Importantly, all these detrimental effects induced by AGEs were reversed by inhibition of NHE1 or suppression of oxidative stress. These pieces of data demonstrated that AGEs may activate NHE1 to induce renal damage, which is related to TGF-β1.

Indexed as

AnimalsDose-Response Relationship, DrugGlutathioneGlycation End Products, AdvancedKidneyL-Lactate DehydrogenaseMaleMalondialdehydeOxidative StressRatsRats, Sprague-DawleySodium-Hydrogen ExchangersGlutathioneGlycation End Products, AdvancedL-Lactate DehydrogenaseMalondialdehydeSodium-Hydrogen Exchangers

Identifiers

PMID26697498
PMCPMC4677205
OpenAlexW2243854106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.